BioSpace News Archive

Drug Development

UK Approves World’s First Omicron-Specific Booster by Moderna

The U.K’s MHRA has granted conditional authorization to Moderna’s newest vaccine candidate, making it the first Omicron-specific COVID-19 booster vaccine approved by a regulatory agency.

August 15, 2022
·
3 min read
·
Vanessa Doctor, RN
Policy

Seagen Loses Patent Battle against Daiichi Sankyo as Merck Waits in the Wings

As the biotech world awaits the announcement of Merck’s anticipated buyout of Seagen, an arbitrator came down on the side of Daiichi Sankyo in a patent battle against the Seattle-based biotech.

August 15, 2022
·
3 min read
·
Mark Terry
Drug Development

Following Failed COVID-19 Treatment, NRx Prioritizes Bipolar Depression Candidate, NRX-101

During the second quarter, NRx reactivated the development of NRX-101 and intends to initiate a Phase IIb/III study for ASIB by the end of this year or early 2023.

August 15, 2022
·
3 min read
·
Alex Keown
Study: SOD1 Protein could have Therapeutic Implications Beyond Familial ALS

In a recently published study, researchers found that the link between the SOD1 protein and Amyotrophic Lateral Sclerosis (ALS) could extend to all types of the motor neuron disease.

August 15, 2022
·
2 min read
·
Katherine Davis
Drug Development

Novartis’ Canakinumab Flunks Another Phase III NSCLC Trial

Novartis released results from the Phase III CANOPY-A trial, showing that its canakinumab candidate failed to meet its primary efficacy endpoint in adult NSCLC patients.

August 15, 2022
·
3 min read
·
Tristan Manalac
Career Advice

Remote Job Options in the Life Science Industry

To help you in your job search, here are just a few of the remote job options in the life science industry, along with the qualifications and skills necessary to be successful in each role.

August 15, 2022
·
5 min read
·
Franklin Carpenter
Drug Development

Why is the Quest for Universal Flu and COVID-19 Vaccines Taking so Long?

After more than two decades of attempts to develop a universal influenza vaccine, the global COVID-19 pandemic intensified the need for a broader vaccine for both illnesses.

August 15, 2022
·
4 min read
·
Gail Dutton
Business

Kelyniam Global Announces 1st Half Results Outstanding Quarter and Sales Momentum into the Second Half

Kelyniam Global, a maker of custom cranial implants, announced results for its quarter ended June 30, 2022.

August 15, 2022
·
2 min read
Substance Abuse Treatment Market: Rising Prevalence of Various Lifestyle Diseases to Drive the Market

Wilmington, Delaware, United States, Transparency Market Research Inc. – The term ‘substance abuse’ refers to a pattern of drug or substance usage that results in serious issues or distress.

August 15, 2022
·
11 min read
Upper Limb Prosthetics Market Trends, On-going Demand, Opportunities, Segmentation, and Forecast till 2030

Wilmington, Delaware, United States, Transparency Market Research Inc. – Current research directions in the upper limb prosthetics market hover around improving the performance outcomes so that the devices meet the functional requirements in amputees.

August 15, 2022
·
6 min read